Related Experiment Video
Updated: Aug 16, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
Screening for primary open-angle glaucoma in the developed world: are we there yet?
Paul Harasymowycz1, Alvine Kamdeu Fansi, Demosthenes Papamatheakis
1Hôpital Maisonneuve-Rosemont, Centre de Recherche Guy-Bernier, Université de Montréal, Department of Ophthalmology, Que. pavloh@hotmail.com
Recent advances in primary open-angle glaucoma (POAG) diagnosis and treatment necessitate re-evaluating POAG screening programs. New technologies and treatments improve early detection and management, potentially making screening more feasible and cost-effective.
Area of Science:
- Ophthalmology
- Public Health
- Health Technology Assessment
Background:
- A 1995 assessment concluded against a formal primary open-angle glaucoma (POAG) screening program in Quebec due to uncertainty and high costs.
- The feasibility of POAG screening requires re-evaluation in light of recent diagnostic and therapeutic advancements.
Purpose of the Study:
- To assess the potential for establishing a POAG screening program.
- To consider recent developments in glaucoma diagnosis and treatment.
Main Methods:
- Review of new developments in glaucoma diagnosis and treatment since the mid-1990s.
- Identification of changes impacting the feasibility and organization of glaucoma screening.
Main Results:
- Advanced technologies (confocal scanning laser ophthalmoscopy, optical coherence tomography, scanning laser polarimetry) enable early detection of structural damage.
- Psychophysical tests (frequency doubling perimetry, short wavelength automated perimetry) aid in earlier functional damage detection.
- Lowering intraocular pressure (IOP) is key; pachymetry influences IOP measurement. New treatments (prostaglandin analogues, selective laser trabeculoplasty) offer improved safety and efficacy.
Conclusions:
- Cost-effectiveness of POAG screening is influenced by the certainty of effective and reliable screening.
- Advancements in diagnosis, treatment, and potential increases in POAG prevalence warrant a re-evaluation of screening programs.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment